ABCG2 p.Ile239Lys

[switch to full view]
Comments [show]
Publications
PMID: 17027309 [PubMed] Li YF et al: "Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling study."
No. Sentence Comment
125 Two other NBD mutations, T237V and I239K (OP and SEB, unpublished results), are located near the conserved H-motif in a surface cleft; while the former was fully functional, the latter could not be detected on the cell surface.
X
ABCG2 p.Ile239Lys 17027309:125:35
status: VERIFIED
Login to comment

127 The side chain of I239, on the other hand, contributes to the hydrophobic core of the protein, and as might be expected from the model, the I239K mutation disrupts the proper folding of the structure and renders the molecule inactive.
X
ABCG2 p.Ile239Lys 17027309:127:140
status: VERIFIED
Login to comment

174 Subsequently, a symmetric dimer Y.-F Li et al. / Journal of Molecular Graphics and Modelling 25 (2007) 837-851844 Table 4 Locations of mutations as predicted by the ABCG2 model and functional correlation Mutation Position in ABCG2 Phenotype Reference V12M N-terminal Membrane localization, SNP, and somewhat lower expression and lower resistance [22] S25Pa N-terminal Low drug resistance for the cell line due to lower expression at cell surface [42] T82Aa NBD, Walker A Low drug resistance for the cell line due to lower expression at cell surface [42] K86M NBD, Walker A No expression at cell surface, retained in the Golgi [43] K86I NBD, Walker A No expressed at cell surface [43] Q141K NBD SNP with lower protein expression and low drug resistance [22,23] T237V NBD Fully functional b I239K,R NBD Loss of expression may be due to structural disruption b R309G Linkerc Low drug resistance [42] D315-6 Linker Deletion mutant for A315 and T316.
X
ABCG2 p.Ile239Lys 17027309:174:789
status: VERIFIED
Login to comment